131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Head and Neck Neoplasm|Skin Neoplasm|Respiratory Tract Neoplasm|Urogenital Neoplasm|Digestive System Neoplasm|Pancreatic Neoplasm|Connective and Soft Tissue Neoplasm|Lymphoma, Non-Hodgkin
Interventions: COMBINATION_PRODUCT: 131I-Tenatumomab
Sponsor: sigma-tau i.f.r. S.p.A.
Collaborators: Medpace, Inc.